EP0540493A1 - Veterinärmedizinisches Instrument für die Abgabe von Arzneimitteln - Google Patents

Veterinärmedizinisches Instrument für die Abgabe von Arzneimitteln Download PDF

Info

Publication number
EP0540493A1
EP0540493A1 EP92870161A EP92870161A EP0540493A1 EP 0540493 A1 EP0540493 A1 EP 0540493A1 EP 92870161 A EP92870161 A EP 92870161A EP 92870161 A EP92870161 A EP 92870161A EP 0540493 A1 EP0540493 A1 EP 0540493A1
Authority
EP
European Patent Office
Prior art keywords
cannula
lower sleeve
cap
udder
channel
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
EP92870161A
Other languages
English (en)
French (fr)
Other versions
EP0540493B1 (de
Inventor
Jan De Backer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
HUBERT DE BACKER NV/SA
Original Assignee
HUBERT DE BACKER NV/SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by HUBERT DE BACKER NV/SA filed Critical HUBERT DE BACKER NV/SA
Publication of EP0540493A1 publication Critical patent/EP0540493A1/de
Application granted granted Critical
Publication of EP0540493B1 publication Critical patent/EP0540493B1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61D—VETERINARY INSTRUMENTS, IMPLEMENTS, TOOLS, OR METHODS
    • A61D1/00—Surgical instruments for veterinary use
    • A61D1/02—Trocars or cannulas for teats; Vaccination appliances

Definitions

  • the cannula only over a portion of the length into the teat canal, so that the drug composition can be deposited directly inside the teat canal.
  • the length of the cannula which can be accommodated inside the teat channel corresponds to the dimension of the opening of the teat channel.
  • the instrument includes: a container for containing a liquid or viscous drug composition, an elongated cannula extending from the container and forming a body with it, and a tubular cap made up of two parts which cover the cannula and can be detached in two parts.
  • the tubular cap indeed comprises a lower sleeve constituted by a removable entry flange which protects the cannula and an upper cap which is rigidly fixed to the lower sleeve and covers the free end of the cannula.
  • the sleeve is shorter in length than the cannula and extends only a portion of the length of the cannula.
  • the sleeve has an upper end having a substantially planar annular end wall, through which the cannula head can be introduced into the udder of the cow through the udder channel when the cap is detached from the lower sleeve.
  • the molding of the cap consisting of two parts is expensive, because it requires not only the acquisition of two different dies and the implementation of two different manufacturing but also an intensive labor since it is necessary to mount two different parts .
  • the flat end of the sleeve offers insufficient sealing and the disadvantage that stains and secretions can be pushed back into the uterus channel and delay the healing of the cow's udder infection.
  • the flat annular end wall also has the drawback of creating an insufficient seal all around the periphery of the upper edge of the lower sleeve when the latter is applied against the udder channel of the cow's udder.
  • the instrument is characterized in that the upper part is integral with the lower sleeve, so that it can be assembled in one piece and the upper cap is separated from the lower sleeve by an annular gap and the end edge of the lower sleeve. forms an annular opening through which the end of the cannula emerges, when the upper cap, intended to cover the end of the cannula, is broken with the thumb and eliminated.
  • the upper cap of the cap of the cannula can be broken up to an annular notch which separates the upper cap from the sleeve.
  • the inner wall of the lower sleeve has projections directed towards the central axis of the lower sleeve, to keep the rather flexible cannula in the middle.
  • the annular orifice has upper edges, the thickness of which provides an air and water tightness zone around the injection point of the udder udder channel, when the drug composition is deposited in the tette channel.
  • the dimension of the upper edge of the periphery of the lower sleeve is chosen as a function of the biomechanical elastic limit of the skin and the flesh of the udder tette.
  • the cannula 3 has a tapered end which must be inserted by sliding into the udder channel 5 of the udder.
  • the length of the cannula is such that, when the cannula 3 is fully introduced into the tette channel 5, the composition drug can be injected directly into the udder 6 ( Figure 8).
  • the free end of the cannula 3 is closed by means of a cap 4 capable of being broken, which covers the cannula 3 over the entire length.
  • This breakable cap 4 is molded in one piece, but it has two parts: a sleeve 7 which is removably mounted on the cannula 3 and an upper part 8 which forms part of the sleeve 7 and covers the free end of the cannula 3.
  • the sleeve 7 is shorter than the cannula 3.
  • the upper part 8 is partially separated from the sleeve by an annular notch 9.
  • the cannula When the cap 4 is detached, the cannula is released over the entire length and it can thus be introduced over the entire length into the udder teat channel.
  • annular opening 12 is formed around the last part of the cannula 3 and of the cap 4.
  • This annular opening 12 offers two important advantages.
  • this opening has the advantage that impurities, in particular secretions or stains, which are located in the vicinity of the orifice of the tette channel 5 on the outside of the udder, can be intercepted in said opening. , when the last portion of length of the cannula 3 is introduced into the tette channel, in which case any risk of introducing stains into the tette disappears.
  • the annular opening 12 then offers the advantage of forming with the tette a watertight contact zone around the entire periphery of the upper edge 10 of the cap 4, in the vicinity of the injection point in the udder, by which prevents leakage of the drug composition to the outside during the injection of the drug composition.
  • the rounded edge 10 of the cap 4 is inserted into the flesh which surrounds the head 11 to a depth sufficient to obtain a sufficient airtightness.
  • the dimension of the contour of the upper edge 10 makes it possible to maintain the contact pressure at the biomechanical elastic limit value of the skin of the pad 11.
  • the contact reaction zone extends over the entire periphery of the sleeve 7, so as to avoid everywhere a leakage of medicinal composition towards the outside.
  • a third advantage lies in the fact that the cap 4 can no longer be reused to close off the tip of the cannula 3, after the upper part 8 of the cap has been broken.
  • the upper part 8 of the cap 4 is in fact used as a sealing ring to guarantee the inviolability of the cannula. It ensures the sterility of the packaging of the instrument filled with medicinal composition.
  • the inner side of the cap includes a sealing cone 14.
  • the upper part 8 is distinguished from a conventional cap by the fact that the closed end is extended by a cylindrical projection 15 which is rigid enough to allow the thumb to rest on it to break the cap at its base and detach it from the cap. 4.
  • the cylindrical part 15 is preferably internally full and provided with external ribs 16 in order to reduce the consumption of synthetic material during molding.
  • the cap 4 according to the invention has the advantage of being able to be manipulated with one hand. This advantage is very important, when it comes to caring for animals that must be held gripped with the other hand.

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Surgery (AREA)
  • Public Health (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Medicinal Preparation (AREA)
  • Materials For Medical Uses (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Closures For Containers (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
EP92870161A 1991-10-31 1992-10-06 Veterinärmedizinisches Instrument für die Abgabe von Arzneimitteln Expired - Lifetime EP0540493B1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
BE9101010A BE1005479A3 (nl) 1991-10-31 1991-10-31 Veeartsenijkundig instrument voor de toediening van een geneesmiddel.
BE9101010 1991-10-31

Publications (2)

Publication Number Publication Date
EP0540493A1 true EP0540493A1 (de) 1993-05-05
EP0540493B1 EP0540493B1 (de) 1996-03-20

Family

ID=3885789

Family Applications (1)

Application Number Title Priority Date Filing Date
EP92870161A Expired - Lifetime EP0540493B1 (de) 1991-10-31 1992-10-06 Veterinärmedizinisches Instrument für die Abgabe von Arzneimitteln

Country Status (9)

Country Link
EP (1) EP0540493B1 (de)
AT (1) ATE135553T1 (de)
BE (1) BE1005479A3 (de)
DE (1) DE69209226T2 (de)
DK (1) DK0540493T3 (de)
ES (1) ES2084990T3 (de)
FI (1) FI103949B (de)
GR (1) GR3019403T3 (de)
NO (1) NO310494B1 (de)

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0755663A1 (de) * 1995-07-28 1997-01-29 FATRO S.p.A. Spritze für die intramammäre Verabreichung von veterinärpharmakologischen Verbindungen
WO2001034059A1 (en) * 1999-11-05 2001-05-17 Eli Lilly And Company Teat infusion syringe and related components
EP1393693A1 (de) * 2002-08-28 2004-03-03 ELM-Plastic GmbH Instrument zur Abgabe eines Arzneimittels
EP1477128A1 (de) * 2003-05-16 2004-11-17 Hubert De Backer NV Baugruppe bestehend aus einer Verschlusskappe und einer intramammären Injektionsspritze
GB2394896B (en) * 2001-09-10 2005-06-22 Bimeda Res & Dev Ltd A bio-security system
WO2008132462A1 (en) * 2007-04-27 2008-11-06 Safeguard Biosystems Holdings Limited Sampling device
US7828765B2 (en) 2004-02-02 2010-11-09 Bimeda Research & Development Ltd Method and device for administering two components into the teat canal of a non-human animal
BE1021349B1 (nl) * 2014-10-10 2015-11-05 Hubert De Backer Nv Afsluitdop met breekrand en injecteerspuit met genoemde afsluitdop
US9180249B2 (en) 2004-02-02 2015-11-10 Bimeda Research & Development Limited Method and device

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0755633T3 (da) 1995-07-28 2000-04-17 Herbert Schlachter Tofasepræparat
NL2001259C1 (nl) 2008-02-05 2009-08-06 Helvoet Rubber & Plastic Techn Speennaald met kopse afschermwand.

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3434473A (en) * 1966-11-15 1969-03-25 Ciba Geigy Corp Hypodermic needle unit with integral needle guard
EP0323109A2 (de) * 1987-12-24 1989-07-05 Diversey Corporation Behandlung von Mastitis und Appliziereinrichtung dafür
US4850970A (en) * 1987-03-26 1989-07-25 American Home Products, Corp. Two part mastitis cannula cap

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3434473A (en) * 1966-11-15 1969-03-25 Ciba Geigy Corp Hypodermic needle unit with integral needle guard
US4850970A (en) * 1987-03-26 1989-07-25 American Home Products, Corp. Two part mastitis cannula cap
EP0323109A2 (de) * 1987-12-24 1989-07-05 Diversey Corporation Behandlung von Mastitis und Appliziereinrichtung dafür

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0755663A1 (de) * 1995-07-28 1997-01-29 FATRO S.p.A. Spritze für die intramammäre Verabreichung von veterinärpharmakologischen Verbindungen
WO2001034059A1 (en) * 1999-11-05 2001-05-17 Eli Lilly And Company Teat infusion syringe and related components
GB2394896B (en) * 2001-09-10 2005-06-22 Bimeda Res & Dev Ltd A bio-security system
EP1393693A1 (de) * 2002-08-28 2004-03-03 ELM-Plastic GmbH Instrument zur Abgabe eines Arzneimittels
EP1477128A1 (de) * 2003-05-16 2004-11-17 Hubert De Backer NV Baugruppe bestehend aus einer Verschlusskappe und einer intramammären Injektionsspritze
EP1477127A1 (de) 2003-05-16 2004-11-17 Hubert De Backer NV Kappe für eine tierärztliche Kanüle
US7828765B2 (en) 2004-02-02 2010-11-09 Bimeda Research & Development Ltd Method and device for administering two components into the teat canal of a non-human animal
US8353877B2 (en) 2004-02-02 2013-01-15 Bimeda Research & Development Limited Method for administering two components into the teat canal of a non-human animal
US9180249B2 (en) 2004-02-02 2015-11-10 Bimeda Research & Development Limited Method and device
WO2008132462A1 (en) * 2007-04-27 2008-11-06 Safeguard Biosystems Holdings Limited Sampling device
BE1021349B1 (nl) * 2014-10-10 2015-11-05 Hubert De Backer Nv Afsluitdop met breekrand en injecteerspuit met genoemde afsluitdop

Also Published As

Publication number Publication date
FI924857A (fi) 1993-05-01
EP0540493B1 (de) 1996-03-20
DK0540493T3 (da) 1996-08-05
GR3019403T3 (en) 1996-06-30
BE1005479A3 (nl) 1993-08-03
ATE135553T1 (de) 1996-04-15
FI924857A0 (fi) 1992-10-26
FI103949B1 (fi) 1999-10-29
DE69209226T2 (de) 1996-07-25
NO924191D0 (no) 1992-10-30
NO924191L (no) 1993-05-03
DE69209226D1 (de) 1996-04-25
FI103949B (fi) 1999-10-29
ES2084990T3 (es) 1996-05-16
NO310494B1 (no) 2001-07-16

Similar Documents

Publication Publication Date Title
EP0540493B1 (de) Veterinärmedizinisches Instrument für die Abgabe von Arzneimitteln
EP0381577A2 (de) Schutzkappe für Injektionsspritzen-Kanüle
EP0410858A2 (de) Abgabevorrichtung für wenigstens ein flüssiges Produkt, insbesondere kosmetischer oder pharmazeutischer Art
FR2673107A1 (fr) Dispositif protecteur pour une aiguille de seringue, de catheter ou d'un instrument medical analogue pour l'utilisation chez l'humain ou chez les animaux.
FR2902675A1 (fr) Buse de distribution de produit de fluide et dispositif de distribution de produit de fluide comprenant une telle buse
FR2654078A1 (fr) Obturateur du canal de sortie d'une tete de distribution pour produits pateux et tete de distribution avantageusement associee.
EP2177450A1 (de) Vorrichtung zur Verteilung von Flüssigkeit, die mit einem unter dem Druckeffekt eines Benutzers verschiebbaren Dichtungsorgan ausgestattet ist
FR2482450A1 (fr) Moyen d'evacuation urinaire externe
EP0266383B1 (de) Vorrichtung zur reinigung eines hohlraums, insbesondere des aurikulären hohlraums
FR2477006A1 (fr) Appareil de transfert d'elements de reproduction animale, notamment d'embryons
FR2773783A1 (fr) Distributeur manuel auto-obturateur
FR2537550A3 (fr) Recipient contenant des substances fluides, destine a etre utilise avec des petites pompes manuelles pour la distribution de ces substances
FR2676714A1 (fr) Recipient muni d'un dispositif elastique de fermeture.
FR2739294A1 (fr) Embout nasal de securite
FR3018703B1 (fr) Dispositif de maintien d'une tetine de pipetage et distributeur compte-gouttes
FR3021861A1 (fr) Dispositif perfectionne de transfert atraumatique de materiel ou substance a but reproductif, therapeutique ou diagnostique dans des mammiferes femelles
FR2653381A1 (fr) Instrument de peinture/ecriture.
FR2739779A1 (fr) Seringue d'aspiration et dispositif d'aspiration comprenant une telle seringue
FR2684004A1 (fr) Seringue medicale munie d'une protection d'aiguille articulee et verrouillable.
FR2746653A3 (fr) Seringue a usage medical
WO1999029584A1 (fr) Dispositif de sortie pour conteneur de fluide
FR2554707A1 (fr) Dispositif pour prelevements sanguins muni d'un systeme d'etancheite
FR2572677A1 (fr) Dispositif de melange et de transfert d'une matiere pateuse en particulier matiere pateuse durcissables pour prise d'empreinte
FR2927888A1 (fr) Flacon comprenant un tube plongeur
FR2458304A1 (fr) Flacon essoreur

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU NL PT SE

17P Request for examination filed

Effective date: 19930614

17Q First examination report despatched

Effective date: 19941128

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

AK Designated contracting states

Kind code of ref document: B1

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU NL PT SE

REF Corresponds to:

Ref document number: 135553

Country of ref document: AT

Date of ref document: 19960415

Kind code of ref document: T

REG Reference to a national code

Ref country code: CH

Ref legal event code: NV

Representative=s name: PATENTANWALTSBUERO EDER AG

REG Reference to a national code

Ref country code: IE

Ref legal event code: FG4D

Free format text: 67667

REF Corresponds to:

Ref document number: 69209226

Country of ref document: DE

Date of ref document: 19960425

REG Reference to a national code

Ref country code: ES

Ref legal event code: FG2A

Ref document number: 2084990

Country of ref document: ES

Kind code of ref document: T3

ITF It: translation for a ep patent filed

Owner name: JACOBACCI & PERANI S.P.A.

REG Reference to a national code

Ref country code: GR

Ref legal event code: FG4A

Free format text: 3019403

GBT Gb: translation of ep patent filed (gb section 77(6)(a)/1977)

Effective date: 19960621

SC4A Pt: translation is available

Free format text: 960320 AVAILABILITY OF NATIONAL TRANSLATION

REG Reference to a national code

Ref country code: DK

Ref legal event code: T3

PLBE No opposition filed within time limit

Free format text: ORIGINAL CODE: 0009261

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT

26N No opposition filed
REG Reference to a national code

Ref country code: GB

Ref legal event code: IF02

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: IE

Payment date: 20120330

Year of fee payment: 20

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: SE

Payment date: 20120330

Year of fee payment: 20

Ref country code: DK

Payment date: 20120330

Year of fee payment: 20

Ref country code: GB

Payment date: 20120330

Year of fee payment: 20

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: DE

Payment date: 20120330

Year of fee payment: 20

Ref country code: CH

Payment date: 20120410

Year of fee payment: 20

Ref country code: LU

Payment date: 20120406

Year of fee payment: 20

Ref country code: BE

Payment date: 20120411

Year of fee payment: 20

Ref country code: NL

Payment date: 20120329

Year of fee payment: 20

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: GR

Payment date: 20120425

Year of fee payment: 20

Ref country code: FR

Payment date: 20120413

Year of fee payment: 20

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: IT

Payment date: 20120330

Year of fee payment: 20

REG Reference to a national code

Ref country code: DE

Ref legal event code: R071

Ref document number: 69209226

Country of ref document: DE

REG Reference to a national code

Ref country code: DK

Ref legal event code: EUP

REG Reference to a national code

Ref country code: DE

Ref legal event code: R071

Ref document number: 69209226

Country of ref document: DE

REG Reference to a national code

Ref country code: NL

Ref legal event code: V4

Effective date: 20121006

REG Reference to a national code

Ref country code: CH

Ref legal event code: PL

REG Reference to a national code

Ref country code: PT

Ref legal event code: MM4A

Free format text: MAXIMUM VALIDITY LIMIT REACHED

Effective date: 20121006

BE20 Be: patent expired

Owner name: S.A. HUBERT *DE BACKER N.V.

Effective date: 20121006

REG Reference to a national code

Ref country code: GB

Ref legal event code: PE20

Expiry date: 20121005

REG Reference to a national code

Ref country code: SE

Ref legal event code: EUG

REG Reference to a national code

Ref country code: GR

Ref legal event code: MA

Ref document number: 960400728

Country of ref document: GR

Effective date: 20121007

REG Reference to a national code

Ref country code: AT

Ref legal event code: MK07

Ref document number: 135553

Country of ref document: AT

Kind code of ref document: T

Effective date: 20121006

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: GB

Free format text: LAPSE BECAUSE OF EXPIRATION OF PROTECTION

Effective date: 20121005

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: PT

Payment date: 20120402

Year of fee payment: 20

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: PT

Free format text: LAPSE BECAUSE OF EXPIRATION OF PROTECTION

Effective date: 20121016

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: AT

Payment date: 20120411

Year of fee payment: 20

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: ES

Payment date: 20120327

Year of fee payment: 20

REG Reference to a national code

Ref country code: IE

Ref legal event code: MM4A

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20121006

REG Reference to a national code

Ref country code: ES

Ref legal event code: FD2A

Effective date: 20140827

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: ES

Free format text: LAPSE BECAUSE OF EXPIRATION OF PROTECTION

Effective date: 20121007

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LU

Free format text: THE PATENT HAS BEEN ANNULLED BY A DECISION OF A NATIONAL AUTHORITY

Effective date: 20111031